This study reveals that PKCδ is not per se a pro-apoptotic kinase and underlines the importance of understanding molecular mechanisms for the evaluation of therapeutic targets in the treatment of diabetes mellitus. This evidence concerns the gene PRKCD and diabetes mellitus.